PATIENT-REPORTED IMPROVEMENTS IN "OFF"-TIME QUALITY, NON-MOTOR FLUCTUATION SEVERITY, AND MEDICATION SATISFACTION IN THE REAL-WORLD OPTION STUDY OF OPICAPONE IN PARKINSON'S DISEASE

被引：0
|
作者：
LeWitt, P. [1 ,2 ]
Klepitskaya, O. [3 ]
Serbin, M. [3 ]
Jen, E. [3 ]
Rattana, S. [4 ]
Trotter, J. [4 ]
Liang, G. [3 ]
机构：
[1] Wayne State Univ, Sch Med, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI USA
[3] Neurocrine Biosci Inc, San Diego, CA USA
[4] Worldwide Clin Trials, Morrisville, NC USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO109
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 33 条
  • [31] Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study
    Hayashi, Yuka
    Nakagawa, Ryoko
    Ishido, Miwako
    Yoshinaga, Yoko
    Watanabe, Jun
    Kurihara, Kanako
    Nagaki, Koichi
    Ogura, Hiromu
    Mishima, Takayasu
    Fujioka, Shinsuke
    Tsuboi, Yoshio
    PARKINSONS DISEASE, 2021, 2021
  • [32] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-B inhibitors (MAO-B) and dopamine agonists (DA): findings from the real-world OPTIPARK study
    Reichmann, H.
    Warnecke, T.
    Lees, A.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S232 - S232
  • [33] Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)
    Liebert, Ariel
    Klopocka, Maria
    Michalak, Agata
    Cichoz-Lach, Halina
    Talar-Wojnarowska, Renata
    Domzal-Magrowska, Danuta
    Konecki, Lukasz
    Filipiuk, Aleksandra
    Krogulecki, Michal
    Kopertowska-Majchrzak, Maria
    Stawczyk-Eder, Kamila
    Waszak, Katarzyna
    Eder, Piotr
    Zagorowicz, Edyta
    Smola, Izabela
    Wojciechowski, Krzysztof
    Drygala, Szymon
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
1234